Study suggests immunotherapy may strengthen treatment for aggressive prostate cancer

Researchers at Moffitt Cancer Center report encouraging early results from a phase 2 study examining whether immunotherapy can improve results when added to a radiotherapy-based treatment regimen for men with aggressive prostate cancer. The work, led by Kosj Yamoah, MD, Ph.D., was published in the Journal for ImmunoTherapy of Cancer.